2 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 2 with minor changes only.
Primary completion pushed from Aug 1, 2027 to Dec 1, 2027
Also in this update: Study completion pushed from Aug 1, 2027 to Jul 1, 2037; Interventions modified
Changhai HospitalNot applicable NCT07074379 Registry history of NCT07074379 on ClinicalTrials.gov (opens the registry)
Updated
Registry marked status Unknown (sponsor has not verified the record since May 2024); last known: Recruiting
Changhai HospitalPhase 2 NCT06394674 Registry history of NCT06394674 on ClinicalTrials.gov (opens the registry)
Changed
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-08 | NCT07866313 Neoadjuvant Chemoradiotherapy Combined With QL1706 for MSS-Type Low-Rectal Cancer | Phase 2/3 | Recruiting |
| 2026-09-18 | NCT07828379 Post-Market Active Surveillance and Health Economic Evaluation of Cerebrovascular… | Not Yet Recruiting |
| Early Phase 1 | 6 | |
| Phase 1 | 6 | |
| Phase 1/2 | 1 | |
| Phase 2 | 9 | |
| Phase 2/3 | 3 | |
| Phase 3 | 1 | |
| Phase 4 | 3 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT07088757 | Low-Dose vs Standard-Dose Indomethacin for Preventing Post-ERCP Pancreatitis | Post-ERCP Pancreatitis | Recruiting | 2025-11-18 |
| NCT06937294 | Metformin in Post Chronic Pancreatitis Diabetes Mellitus | Chronic Pancreatitis | Recruiting | 2025-05-21 |
| NCT05814848 | A Study of Secondary Infusion of Relmacabtagene Autoleucel Injection for Relapsed or… | Relapsed or Refractory B-cell Lymphoma | Not Yet Recruiting | 2023-06-15 |
| Phase 3 | ||||
| NCT06427447 | Adjuvant Chemoradiotherapy Versus Chemotherapy for Pancreatic Cancer (ADJUPANC) | Pancreatic Cancer | Recruiting | 2025-02-04 |
| Phase 2/3 | ||||
| NCT07866313 | Neoadjuvant Chemoradiotherapy Combined With QL1706 for MSS-Type Low-Rectal Cancer | MSS-type Low Rectal Cancer，Neoadjuvant Chemoradiotherapy, QL1706 | Recruiting | 2026-10-08 |
| NCT07047339 | Evaluate the Efficacy and Safety of Probiotic 6600 as an Adjuvant Therapy for Colitis | Colitis | Recruiting | 2025-07-02 |
| NCT07134218 | Neoadjuvant Chemoradiotherapy Combined With Immunotherapy and Anti-angiogenesis in… | Rectal Cancer | Not Yet Recruiting | 2025-08-21 |
| Phase 2 | ||||
| NCT07307456 | Toripalimab Combined With BCG Perfusion for the Treatment of HR-NMIBC After TURBT Surgery… | Bladder Cancer | Recruiting | 2026-07-21 |
| NCT07492693 | Efficacy and Safety of Hetrombopag in Preventing Chemotherapy-induced Thrombocytopenia in… | Chemotherapy-induced Thrombocytopenia (CIT) in Patients With Gastrointestinal Tumors | Recruiting | 2026-03-25 |
| NCT06427460 | Central-boost Ablative Radiation Therapy for Solid Tumors (CBART) | Pancreatic Cancer | Recruiting | 2024-05-23 |
| NCT07691593 | Neoadjuvant HRS-4642 Plus Chemotherapy With or Without Immunotherapy for Pancreatic Cancer | Pancreatic Cancer | Not Yet Recruiting | 2026-07-09 |
| NCT07492225 | Neoadjuvant Chemotherapy Before Surgery vs Surgery Alone for UTUC: A Randomized Trial | Neoadjuvant Therapy | Active, Not Recruiting | 2026-03-25 |
| NCT07490002 | Neoadjuvant Therapy With Iparomlimab and Tuvonralimab, Lenvatinib and Chemotherapy in… | Esophageal Squamous Carcinoma | Not Yet Recruiting | 2026-03-24 |
| NCT06927128 | Neoadjuvant Chemotherapy in High - Risk Upper Tract Urothelial Carcinoma | UTUC | Not Yet Recruiting | 2025-04-15 |
| NCT06210360 | Perioperative Treatment in High-risk Resectable Pancreatic Cancer With NALIRIFOX | Pancreatic Cancer | Not Yet Recruiting | 2024-01-18 |
| NCT06014944 | Short-course Radiotherapy Combined With Furoquintinib and PD-1 Monoclonal Antibody | Rectal Cancer | Not Yet Recruiting | 2023-08-31 |
| Phase 1/2 | ||||
| NCT04146298 | Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Pancreatic Cancer | Pancreatic Cancer | Recruiting | 2025-12-24 |
| Phase 1 | ||||
| NCT07425483 | CAR-NK Cells (CL-NK-003) in Pancreatic Cancer | Pancreatic Cancer | Recruiting | 2026-02-23 |
| NCT06464679 | An Exploratory Clinical Study of CD19 CAR NK Cell Injection for the Treatment of… | Autoimmune Diseases | Recruiting | 2025-08-29 |
| NCT06885710 | HBV-Specific TCR-T Cell Therapy Combined With Nucleos(t)Ide Analogues in Chronic… | Chronic Hepatitis b | Recruiting | 2025-07-17 |
| NCT06816823 | CAR-NK Cells (CL-NK-001) in Pancreatic Cancer | Pancreatic Cancer | Recruiting | 2025-06-04 |
| NCT05240950 | Anti-CEA CAR-T Cells to Treat Colorectal Liver Metastases | Colorectal Cancer | Recruiting | 2022-03-11 |
| NCT07583160 | YS247 (Neoantigen-Pulsed DC Vaccine) for Metastatic Prostate Cancer | Metastatic Castration-Resistant Prostate Cancer Patients | Enrolling by Invitation | 2026-05-13 |
| Early Phase 1 | ||||
| NCT06469190 | An Exploratory Clinical Study of Anti-CD19 CAR NK Cell (KN5501) in the Treatment of… | Nephropathy | Recruiting | 2026-06-26 |
| NCT07246096 | Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell… | Autoimmune Diseases | Recruiting | 2026-02-25 |
Pancreatic Cancer (14) · Bladder Cancer (7) · Colorectal Cancer (7) · Heart Disease (6) · Prostate Cancer (6) · Gastric Cancer (4) · Coronary Artery Disease (3) · Esophageal Cancer (3) · Stroke (3) · Atrial Fibrillation (2)